Newsletter: Vol. 6, No. 1, May 2022

In this issue, read about published research on the outcomes and safety of history-based screening for medication abortion as well as new research on an approach to medication abortion provision without real-time interactions between client and clinician, a retrospective review on misoprostol alone for medication abortion by mail, and the feasibility of introducing a new screening tool for preeclampsia. Find out also about our current speaking engagements.

Read the full Newsletter.